Welch Allyn has partnered with Nonin Medical, a designer and manufacturer of noninvasive medical monitoring solutions, to provide its clinically proven PureSAT SpO2 technology. The partnership allows Welch Allyn to offer technologies from three leading manufacturers as part of its next generation vital signs device that allows customizable vital signs capture, interval monitoring and wireless transfer of patient data to the electronic medical record (EMR).
“Blood oxygen level (SpO2) is an important vital sign that provides feedback on a patient’s overall health status,” says Shawn St. Pierre, senior global category manager, vital signs, at Welch Allyn. “Clinicians see patients ranging from newborns through older adults, and require devices capable of providing accurate measurements across these populations and in the presence of varying medical conditions. With technologies constantly evolving, offering solutions from Masimo, Nonin Medical, and Covidien provides our customers with access to more innovations and the ability to select solutions that best match their performance needs.”
Nonin Medical’s clinically proven PureSAT pulse oximetry technology delivers fast and reliable readings by utilizing intelligent pulse-by-pulse filtering to provide precise oximetry measurements — even in the presence of motion, low perfusion or other challenging conditions. PureSAT signal processing pre-filters the pulse signals to remove undesirable signals and advanced algorithms then separate the pulse signals from artifact and interference.
“Nonin Medical is excited to partner with Welch Allyn in providing pulse oximetry solutions that improve the quality of patient care while lowering the cost and improving the processes of care delivery,” said Mark VanderWerf, vice president of strategic relationships, oem and mHealth for Nonin Medical. “Nonin and Welch Allyn share a Culture of Integrity — in terms of service, performance and value that customers can count on far beyond the sale. Working with Welch Allyn has been a pleasure and we look forward to a long-term, mutually beneficial relationship.” •